Exciting news! 🎉 Qwark’s AI pharmacy assistant (in beta) is now live and ready to answer any medication-related questions you may have!Try it out now!
  1. Drugs
  2. ›
  3. Viibryd Starter Pack
Viibryd Starter Pack Image

Viibryd Starter Pack

Free shipping
No membership fee
Qwark price promise
Qwark is committed to lowering your prescription prices. We will always recommend the best price we can find. If you find a lower price on an identical, in-stock product, tell us and we'll match it.

For more strengths and prices, please contact Qwark support

Need help?

Our patient support team is available Monday through Friday 8AM - 6PM PST, and Saturday 9AM - 12PM PST.

What Is Viibryd Starter Pack?

The Viibryd Starter Pack is a medication used in the treatment of major depressive disorder (MDD). It belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). The starter pack is specifically designed to help patients initiate treatment with Viibryd. It contains a range of dosage options, allowing healthcare providers to gradually increase the dose based on the patient's individual needs. This helps to minimize potential side effects and optimize the desired therapeutic effect. Viibryd works by increasing the levels of serotonin, a neurotransmitter in the brain that is associated with mood regulation. By selectively blocking the reuptake of serotonin, it helps to maintain higher levels of serotonin in the brain, which can improve mood and alleviate symptoms of depression. It is important to note that Viibryd may take several weeks to exert its full therapeutic effects, and it is essential to take the medication as prescribed by a healthcare professional. Additionally, like all medications, Viibryd may cause side effects, including nausea, diarrhea, headache, and sexual dysfunction. These side effects typically subside over time or can be managed with dose adjustments or other interventions. As with any medication, it is crucial to discuss the potential risks and benefits with your healthcare provider before starting treatment with Viibryd. They will be able to assess whether Viibryd is the right choice for you and provide appropriate guidance throughout the treatment process.

How to use Viibryd Starter Pack?

The Viibryd Starter Pack is a medication used to treat major depressive disorder (MDD). It is an antidepressant that belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs). When beginning treatment with Viibryd, it is important to follow certain guidelines to ensure its proper use. The Viibryd Starter Pack typically contains a specific combination of tablets that are taken at different times during the initial stages of treatment. It is intended to help your body gradually adjust to the medication. To use the Viibryd Starter Pack: 1. Start with the lowest dose: Begin by taking the tablet that corresponds to the lowest dose indicated in the Starter Pack. This is usually taken once daily with food. 2. Follow the prescribed schedule: Take the tablets in the Starter Pack according to the specific schedule recommended by your healthcare provider. This schedule is designed to gradually increase the dose over a period of time. 3. Take the tablets as directed: Swallow the tablets whole with water. Do not break, crush, or chew them. 4. Continue with maintenance dose: Once you have completed the Starter Pack, your healthcare provider will determine the appropriate maintenance dose of Viibryd for you. You will then continue with this dose on a regular basis. 5. Follow your healthcare provider's instructions: It is crucial to follow your healthcare provider's instructions regarding the dosage, frequency, and duration of Viibryd treatment. If you have any questions or concerns, do not hesitate to consult with them. Remember, Viibryd may take several weeks to reach its full effect, so it is important to be patient and consistent with your medication. If you experience any side effects or adverse reactions, notify your healthcare provider promptly. They will be able to provide further guidance and support throughout your treatment.

When it comes to the use of the Viibryd Starter Pack, there are several important warnings that individuals should be aware of. This medication is an antidepressant classified as a selective serotonin reuptake inhibitor (SSRI). Here are the associated warnings: 1. Suicidal thoughts and behavior: Antidepressants like Viibryd may increase the risk of suicidal thoughts and behaviors, particularly in young adults and adolescents. Close monitoring is crucial during the initial weeks of treatment or whenever there is a change in dosage. 2. Serotonin syndrome: Using Viibryd with other medications that increase serotonin levels, such as triptans or certain antidepressants, can lead to a potentially life-threatening condition called serotonin syndrome. Symptoms include agitation, hallucinations, rapid heartbeat, fever, muscle stiffness, and nausea. Seeking immediate medical attention is important if these symptoms occur. 3. Allergic reactions: Some individuals may experience severe allergic reactions to Viibryd. Symptoms may include rash, itching, swelling, severe dizziness, and difficulty breathing. Emergency medical assistance should be sought if these symptoms occur. 4. Activation of mania/hypomania: For individuals with bipolar disorder, treatment with SSRIs like Viibryd may trigger a manic or hypomanic episode. Close monitoring is important to identify any signs of unusual behavior or mood changes. 5. Withdrawal symptoms: Abruptly stopping Viibryd or rapidly decreasing the dosage may lead to withdrawal symptoms such as dizziness, nausea, headache, irritability, and sleep disturbances. Tapering off the medication under medical supervision is advised. 6. Bleeding risk: SSRIs, including Viibryd, may increase the risk of bleeding or bruising, especially when combined with medications like nonsteroidal anti-inflammatory drugs (NSAIDs) or anticoagulants. It is important to consult with a healthcare professional to discuss any specific concerns or questions related to Viibryd and its potential warnings.

Before taking the Viibryd Starter Pack, it is important to be aware of certain warnings and precautions. This medication is an antidepressant that belongs to a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Here are a few key points to consider: 1. Suicidal Thoughts or Behavior: Antidepressants, including Viibryd, may increase the risk of suicidal thoughts or behavior, especially in children, adolescents, and young adults. Close monitoring is crucial, particularly during the initial weeks of treatment and dosage adjustments. 2. Serotonin Syndrome: This is a potentially life-threatening condition that can occur when there is an excessive buildup of serotonin in the body. Symptoms may include agitation, hallucinations, rapid heartbeat, fever, nausea, vomiting, diarrhea, and muscle stiffness. Contact your healthcare provider immediately if you experience any of these symptoms. 3. Allergic Reactions: In rare cases, Viibryd can cause severe allergic reactions. Seek immediate medical attention if you notice symptoms such as rash, itching, swelling, severe dizziness, or difficulty breathing. 4. Activation of Mania/Hypomania: Some individuals with depression may experience a shift to manic or hypomanic episodes while taking antidepressants, including Viibryd. If you experience heightened energy, increased mood swings, or unrealistic thoughts, inform your doctor promptly. 5. Withdrawal Symptoms: Abruptly discontinuing Viibryd can lead to withdrawal symptoms such as mood swings, irritability, dizziness, and sleep disturbances. To avoid these effects, it is important to gradually reduce the dosage under medical supervision. Remember, it is essential to discuss your medical history, current medications, and any concerns with your healthcare provider before starting Viibryd or any other medication. They will be able to assess if this medication is suitable for your specific situation and provide appropriate guidance.

The Viibryd Starter Pack is commonly prescribed as an antidepressant for the treatment of major depressive disorder (MDD). Being a selective serotonin reuptake inhibitor (SSRI), it works by increasing the availability of serotonin, a neurotransmitter that helps regulate mood, in the brain. While Viibryd can be beneficial in managing symptoms of depression, it is important to be aware of potential side effects. Common side effects that may occur with Viibryd include nausea, vomiting, diarrhea, dizziness, insomnia, abnormal dreams, and dry mouth. These side effects are usually mild and temporary, but if they persist or become bothersome, it is recommended to consult with a healthcare provider. In some cases, Viibryd may also cause more serious side effects that require immediate medical attention. These can include allergic reactions, severe mood changes, suicidal thoughts or behaviors, abnormal bleeding, or serotonin syndrome (characterized by symptoms such as agitation, hallucinations, rapid heartbeat, fever, muscle stiffness, and coordination problems). If any of these severe side effects occur, it is crucial to seek medical help right away. As with any medication, individual experiences may vary, and it is important to discuss any concerns or side effects with a healthcare provider. They can provide more specific information based on an individual's medical history and overall health.

The Viibryd Starter Pack contains two different strengths of the medication, each with their own set of ingredients. The starter pack is designed to help patients gradually adjust to the full dosage of the medication. Here are the ingredients for each strength: For the 10 mg tablets: - Active ingredient: Vilazodone hydrochloride - Inactive ingredients: Microcrystalline cellulose, pregelatinized starch, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol, and iron oxide yellow. For the 20 mg tablets: - Active ingredient: Vilazodone hydrochloride - Inactive ingredients: Microcrystalline cellulose, pregelatinized starch, croscarmellose sodium, colloidal silicon dioxide, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol, and iron oxide red. It's important to note that these inactive ingredients are commonly used in pharmaceutical formulations and are generally considered safe for most individuals. However, individuals with known allergies or sensitivities to any of these ingredients should consult with their healthcare provider before taking Viibryd or any other medication. As an SSRI, Viibryd works by increasing the availability of serotonin in the brain, which helps improve mood and alleviate symptoms of depression. It is generally well-tolerated but may cause side effects such as nausea, diarrhea, insomnia, or sexual dysfunction. It is important to follow your healthcare provider's instructions and report any concerning side effects.

The Viibryd Starter Pack, like any medication, should be stored according to specific guidelines to ensure its effectiveness and safety. It is important to follow the storage instructions provided by the manufacturer and your healthcare provider. Here are some general guidelines for storing the Viibryd Starter Pack: 1. Temperature: Store the medication at room temperature, typically between 68°F and 77°F (20°C and 25°C). 2. Moisture: Keep the medication in a dry place, away from any moisture or humidity. Avoid storing it in the bathroom, as the moisture from showers can affect its potency. 3. Light: Protect the medication from direct sunlight or excessive light exposure. It is recommended to store it in its original packaging, which usually provides adequate protection. 4. Childproof container: Keep the Viibryd Starter Pack in a childproof container, out of reach of children and pets. This is important to prevent accidental ingestion. Always check the expiration date on the packaging and dispose of any expired medication properly. If you have any doubts about the storage of your Viibryd Starter Pack, consult your pharmacist or healthcare provider for further guidance.